People · Operator
Named in public records as an officer, director or promoter · active 2005–2025 · Investment Vehicle, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Thompson Builders Fund LLC | — | Investment Vehicle | Series D+ | $250.0M | $2.0B | 2025 |
| Sound Pharmaceuticals Inc | — | Biotechnology | Series A | $21.6M | $304.0M | 2005 |
| Chaikin Analytics, LLC | — | Other Technology | Seed | $6.0M | $13.1M | 2013 |
Paul Thompson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Thompson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Guyer | 1 | 8 |
| James C. Towne | 1 | 4 |
| James Paul Rickey | 1 | 3 |
| Joseph Ashley | 1 | 3 |
| Tom Saleh | 1 | 2 |
| John C. Sullivan | 1 | 2 |
| Glenn Kawasaki | 1 | 2 |
| Michael Demson | 1 | 1 |
| Ronald Gordon | 1 | 1 |
| Alison Sullivan-Wagner | 1 | 1 |
| Joseph Hill | 1 | 1 |
| Christopher Castroviejo | 1 | 1 |
| Marc Chaikin | 1 | 1 |
| Eric Lynch | 1 | 1 |
| Jonathan Kil | 1 | 1 |
| Keith Kammer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.